Cohlhepp Ryan (CIK 2034665) reported 40 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-12). Recent activity: Buy BCAX (18,750 shares), Sell BCAX (18,750 shares), Buy BCAX (18,750 shares), Sell BCAX (22,833 shares), Sell BCAX (4,306 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Bicara Therapeutics Inc. (BCAX) | President and COO | Buy | 18,750 | $71,059 |
| 2026-08-12 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 18,750 | $524,533 |
| 2026-07-10 | Bicara Therapeutics Inc. (BCAX) | President and COO | Buy | 18,750 | $71,059 |
| 2026-07-10 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 22,833 | $656,652 |
| 2026-07-10 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 4,306 | $128,302 |
| 2026-07-10 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 1,075 | $32,632 |
| 2026-07-10 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 536 | $15,544 |
| 2026-05-18 | Bicara Therapeutics Inc. (BCAX) | President and COO | Buy | 8,000 | $30,318 |
| 2026-05-18 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 8,000 | $162,335 |
| 2026-05-18 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 4,500 | $91,314 |
| 2026-04-17 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 4,500 | $103,533 |
| 2026-04-17 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 8,000 | $184,058 |
| 2026-04-17 | Bicara Therapeutics Inc. (BCAX) | President and COO | Buy | 8,000 | $30,318 |
| 2026-03-17 | Bicara Therapeutics Inc. (BCAX) | President and COO | Buy | 8,000 | $30,320 |
| 2026-03-17 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 8,000 | $157,280 |
| 2026-03-17 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 4,500 | $88,470 |
| 2026-03-05 | Bicara Therapeutics Inc. (BCAX) | President and COO | Buy | 12,892 | $48,861 |
| 2026-03-05 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 12,892 | $234,119 |
| 2026-03-05 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 4,500 | $81,720 |
| 2026-02-27 | Bicara Therapeutics Inc. (BCAX) | President and COO | Buy | 3,108 | $11,779 |
| 2026-02-27 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 3,108 | $56,068 |
| 2026-02-27 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 523 | $9,435 |
| 2026-01-26 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 3,828 | $69,287 |
| 2026-01-20 | Bicara Therapeutics Inc. (BCAX) | President and COO | Sell | 149 | $2,685 |
| 2025-12-29 | Bicara Therapeutics Inc. (BCAX) | President and COO | Buy | 25,000 | $111,000 |
Source: SEC Form 4 filings · as of 2026-08-12